RFA-MH-18-702 - Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest to Highlight High Priority Opportunities for Intervention Development Research in Geriatric Mental Health | NOT-MH-20-027 | NIMH | Mar 19, 2020 | Sep 8, 2023 | R01, R21, R61/R33, R34 |
Notice of Special Interest: NIMHs Interest in Early Stage Clinical and/or Mechanistic Trials in Posttraumatic Psychopathology, Directed at Testing FAAH Inhibitors | NOT-MH-19-055 | NIMH | Oct 17, 2019 | Jan 8, 2022 | U01, R61/R33, R21, R01 |